{"title":"医学实验室评审:ISO 15189:2022 的新内容","authors":"Kyriacos C. Tsimillis, Sappho Michael","doi":"10.1007/s00769-024-01576-z","DOIUrl":null,"url":null,"abstract":"<div><p>In this paper, the main changes in ISO 15189:2022 in comparison with the 2012 version are discussed. They affect, directly or indirectly, the actions of medical laboratories towards ensuring validity and accuracy of examination results. A main change refers to the structure that is now aligned with ISO/IEC 17025 and recent editions of other standards in the ISO 17000 series. Further to this, requirements for medical laboratories to plan and implement actions addressing risks and opportunities are introduced in the new standard. This is part of the overall philosophy of the Standard and is reflected in almost all its clauses, mainly those dealing with the pre-examination, the examination and the post-examination processes. Great emphasis is given to sampling and the pre-examination process. Contrary to ISO/IEC 17025, uncertainty arising from sampling is not referred to; this seems to be related to inherent difficulties for such an evaluation. Requirements for equipment calibration and metrological traceability of measurement results are more detailed; similarly, the specific clause on ensuring the validity of examination results, specifying requirements for the internal quality control (IQC), the external quality assessment (EQA) and the comparability of examination results is also more detailed. A new important clause refers to continuity and emergency. The new standard includes requirements for point-of-care testing (POCT) activities, previously included in ISO 22870. Some flexibility on how to meet management requirements is given. Reference is made to a number of additional supporting standards.</p></div>","PeriodicalId":454,"journal":{"name":"Accreditation and Quality Assurance","volume":"29 2","pages":"175 - 182"},"PeriodicalIF":0.8000,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Accreditation of medical laboratories: What is new in ISO 15189:2022\",\"authors\":\"Kyriacos C. Tsimillis, Sappho Michael\",\"doi\":\"10.1007/s00769-024-01576-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In this paper, the main changes in ISO 15189:2022 in comparison with the 2012 version are discussed. They affect, directly or indirectly, the actions of medical laboratories towards ensuring validity and accuracy of examination results. A main change refers to the structure that is now aligned with ISO/IEC 17025 and recent editions of other standards in the ISO 17000 series. Further to this, requirements for medical laboratories to plan and implement actions addressing risks and opportunities are introduced in the new standard. This is part of the overall philosophy of the Standard and is reflected in almost all its clauses, mainly those dealing with the pre-examination, the examination and the post-examination processes. Great emphasis is given to sampling and the pre-examination process. Contrary to ISO/IEC 17025, uncertainty arising from sampling is not referred to; this seems to be related to inherent difficulties for such an evaluation. Requirements for equipment calibration and metrological traceability of measurement results are more detailed; similarly, the specific clause on ensuring the validity of examination results, specifying requirements for the internal quality control (IQC), the external quality assessment (EQA) and the comparability of examination results is also more detailed. A new important clause refers to continuity and emergency. The new standard includes requirements for point-of-care testing (POCT) activities, previously included in ISO 22870. Some flexibility on how to meet management requirements is given. Reference is made to a number of additional supporting standards.</p></div>\",\"PeriodicalId\":454,\"journal\":{\"name\":\"Accreditation and Quality Assurance\",\"volume\":\"29 2\",\"pages\":\"175 - 182\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accreditation and Quality Assurance\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00769-024-01576-z\",\"RegionNum\":4,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accreditation and Quality Assurance","FirstCategoryId":"5","ListUrlMain":"https://link.springer.com/article/10.1007/s00769-024-01576-z","RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
摘要
本文讨论了 ISO 15189:2022 与 2012 版相比的主要变化。这些变化直接或间接地影响着医学实验室为确保检查结果的有效性和准确性而采取的行动。其中一个主要变化是其结构与 ISO/IEC 17025 和 ISO 17000 系列中其他标准的最新版本保持一致。此外,新标准还要求医学实验室计划并实施应对风险和机遇的行动。这是该标准总体理念的一部分,体现在几乎所有条款中,主要是涉及检查前、检查和检查后流程的条款。取样和预检过程受到高度重视。与 ISO/IEC 17025 标准相反,该标准没有提及取样产生的不确定性;这似乎与此类评估的固有困难有关。对设备校准和测量结果的计量溯源性的要求更加详细;同样,关于确保检查结果有效性的具体条款也更加详细,规定了内部质量控制 (IQC)、外部质量评估 (EQA) 和检查结果可比性的要求。一个新的重要条款涉及连续性和应急问题。新标准包括了对护理点检测(POCT)活动的要求,这些要求以前包含在 ISO 22870 中。在如何满足管理要求方面给予了一定的灵活性。此外,还参考了其他一些辅助标准。
Accreditation of medical laboratories: What is new in ISO 15189:2022
In this paper, the main changes in ISO 15189:2022 in comparison with the 2012 version are discussed. They affect, directly or indirectly, the actions of medical laboratories towards ensuring validity and accuracy of examination results. A main change refers to the structure that is now aligned with ISO/IEC 17025 and recent editions of other standards in the ISO 17000 series. Further to this, requirements for medical laboratories to plan and implement actions addressing risks and opportunities are introduced in the new standard. This is part of the overall philosophy of the Standard and is reflected in almost all its clauses, mainly those dealing with the pre-examination, the examination and the post-examination processes. Great emphasis is given to sampling and the pre-examination process. Contrary to ISO/IEC 17025, uncertainty arising from sampling is not referred to; this seems to be related to inherent difficulties for such an evaluation. Requirements for equipment calibration and metrological traceability of measurement results are more detailed; similarly, the specific clause on ensuring the validity of examination results, specifying requirements for the internal quality control (IQC), the external quality assessment (EQA) and the comparability of examination results is also more detailed. A new important clause refers to continuity and emergency. The new standard includes requirements for point-of-care testing (POCT) activities, previously included in ISO 22870. Some flexibility on how to meet management requirements is given. Reference is made to a number of additional supporting standards.
期刊介绍:
Accreditation and Quality Assurance has established itself as the leading information and discussion forum for all aspects relevant to quality, transparency and reliability of measurement results in chemical and biological sciences. The journal serves the information needs of researchers, practitioners and decision makers dealing with quality assurance and quality management, including the development and application of metrological principles and concepts such as traceability or measurement uncertainty in the following fields: environment, nutrition, consumer protection, geology, metallurgy, pharmacy, forensics, clinical chemistry and laboratory medicine, and microbiology.